Hepatitis B Virus News and Research

RSS

Research reveals new details of HIV life cycle

Research by a multi-institutional team, including two members from the University of Delaware, has revealed new details about the HIV virus capsid structure and how it develops.

5 Oct 2018

Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US

Gilead Sciences, Inc. announced today plans to launch authorized generic versions of Epclusa and Harvoni, Gilead's leading treatments for chronic hepatitis C virus, in the United States, through a newly created subsidiary, Asegua Therapeutics LLC.

24 Sep 2018

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

24 Sep 2018

Researchers identify Zika virus proteins with potential to affect brain development

In healthy individuals, the Zika virus causes flu-like symptoms. If a pregnant woman becomes infected, the unborn child can suffer from severe brain abnormalities as a result of mechanisms that have not yet been explained.

4 Sep 2018

Kidney transplantation can be safely performed using organs from patients who had HCV

Researchers at Loma Linda University Health found that kidney transplantation can be safely performed using organs testing positive for the hepatitis C virus antibody but negative for active viral infection.

23 Aug 2018

FIND and genedrive announce study agreement to evaluate HCV ID Kit

genedrive plc, a near patient molecular diagnostics company, and the Foundation for Innovation of New Diagnostics (FIND), announced today a study agreement for the performance evaluation of genedrive plc’s hepatitis C virus (HCV) Genedrive HCV ID Kit.

10 Aug 2018

Researchers provide new insight on origins and global spread of HBV

Researchers have provided new insight on the geographical origins and global spread of two classes of the hepatitis B virus (HBV), according to a study in eLife.

7 Aug 2018

Scientists identify two potential new drug targets for treatment of HIV

Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV - the virus that causes AIDS - and the hepatitis C virus.

7 Aug 2018

New study finds key factors behind differences in immune responses

Age, sex, and specific human genetic variants are the key factors behind differences between immune responses among healthy humans, finds a study of 1,000 individuals carried out by EPFL and the Pasteur Institute.

6 Aug 2018

Researchers find possible active substance that may cure hepatitis E

An international team of researchers has now found a possible active substance against the virus in the naturally occurring substance silvestrol.

1 Aug 2018

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

An estimated 2.3 million people globally are infected with both human immunodeficiency virus type 1 and hepatitis C virus.

27 Jul 2018

Researchers emphasize need for baby boomers to get tested for hepatitis C

According to the Centers for Disease Control and Prevention, 300 million people across the globe are unaware they're living with viral hepatitis. In fact, baby boomers - those born between 1945-1965 - are five times more likely to have hepatitis C, one of the many different strains of this viral infection.

27 Jul 2018

HCV testing can be successfully implemented in emergency department setting

Boston Medical Center has shown that testing for the Hepatitis C Viru outside the typical high-risk population can be successfully implemented in an emergency department setting, resulting in more patients being screened, diagnosed and treated who might not have been otherwise.

23 Jul 2018

Hepatitis B Virus News and Research

Research reveals new details of HIV life cycle

Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Researchers identify Zika virus proteins with potential to affect brain development

Kidney transplantation can be safely performed using organs from patients who had HCV

FIND and genedrive announce study agreement to evaluate HCV ID Kit

Researchers provide new insight on origins and global spread of HBV

Scientists identify two potential new drug targets for treatment of HIV

New study finds key factors behind differences in immune responses

Researchers find possible active substance that may cure hepatitis E

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

Researchers emphasize need for baby boomers to get tested for hepatitis C

HCV testing can be successfully implemented in emergency department setting

Analysis reveals disparities in cancer death rates among minority groups

New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Researchers trace history of human Hepatitis B in the Bronze Age

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News